Senior insider sale
See Remarks at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$198.5K
63.66K shares
What this filing means
SHAH GAURAV plans to sell 63.66K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $198.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001959173-26-005994
DirectorOfficer· See Remarks
Since Jan 2019
63.66K
Shares to sell
$198.5K
Approx. market value
2.84K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
8/11/2026
2.84KTotal acquired2.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/11/2026 | Restricted Stock Vesting Compensation | 2.84K | — |
| Total | 2.84K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
55.68K
Market value
$171.8K
5/21/2026
—Completed
Units to sell
2.41K
Market value
$7.3K
5/19/2026
—Completed
Units to sell
2.73K
Market value
$9.8K
5/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.84K
Market value
$9.6K
8/13/2026
Total
Units
63.66K
Value
$198.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/21/2026 | 55.68K | $171.8K | — | Completed |
5/19/2026 | 2.41K | $7.3K | — | Completed |
5/13/2026 | 2.73K | $9.8K | — | Completed |
| Planned — Approximate Date | ||||
8/13/2026 | 2.84K | $9.6K | NASDAQ | Planned |
| Total | 63.66K | $198.5K | ||